Frequency of the apolipoprotein E ε4 allele in a case-control study of early onset Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 4, 1996, Pages 347-351

  Whitehead, Alexander S ^a   Bertrandy, Solange ^a   Finnan, Finola ^b   Butler, Aileen ^a   Smith, George Davey ^c   Ben Shlomo, Yoav ^c,d,e  

^a Biotechnology Institute

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Canynge Hall ^*  (United Kingdom)

Author keywords

Apolipoprotein 4; Case control study; Meta analysis; Parkinson's disease

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE DURATION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SMOKING;

EID: 0029955915     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.4.347     Document Type: Article

References (51)

1. Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson's disease in a Scottish city. BMJ 1986;292:534-6.
2. Ben-Shlomo Y, Sieradzan K. Idiopathic Parkinson's disease: epidemiology, diagnosis and management. Br J Gen Pract 1995;45:261-8.
3. Jenner P, Schapira AHV, Marsden CD. New insights into the cause of Parkinson's disease. Neurology 1992;42: 2241-50.
4. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240:622-30.
5. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other tissues of rats and marmosets. Proc Natl Acad Sci USA 1985;82:203-7.
6. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-31.
7. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with non-myelinating glia of the peripheral nervous system. J Clin Invest 1985;76: 1501-13.
8. Poirier J, Hess M, May PC, Finch CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991;11:97-106.
9. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:1977-81.
10. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
11. van Duijn CM, Knijff PD, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genetics 1994;7:74-8.
12. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994;309:636-8.
13. Harrington CR, Louwagie J, Rossau R, et al. Infuence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994;145: 1472-84.
14. Arai H, Higuchi S, Muramatsu T, Iwatsubo T, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease. Lancet 1994;344:1307.
15. Pickering-Brown SM, Mann DMA, Bourke JP, et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet 1994;343:1155.
16. Benjamin R, Leake A, Edwardson JA, et al. Apolipoprotein E genes in Lewy body and Parkison's disease. Lancet 1994;343:1565.
17. St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A. Apolipoprotein E ε4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 1994;176:45-6.
18. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ε4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1.
19. Calne DB, McGeer E, Eisen A, Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interactions between ageing and environment. Lancet 1986;ii:1067-70.
20. Ben-Shlomo Y, Whitehead AS, Davey Smith G. Parkinson's, Alzheimer's, and motor neurone disease: clinical and pathological overlap may suggest common genetic and environmental factors. BMJ 1996;312:724.
21. Hofman A, Schulte W, Tanja TA, et al. History of dementia and Parkinson's disease in Ist-degree relatives of patients with Alzheimer's disease. Neurology 1989;39:1589-92.
22. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994;44:1872-7.
23. Forno LS. The Lewy body in Parkinson's disease. Adv Neurol 1987;45:35-43.
24. Agid Y. Parkinson's disease: pathophysiology. Lancet 1991; 337:1321-23.
25. Brown RG, Marsden CD. How common is dementia in Parkinson's disease. Lancet 1984;i:1262-5.
26. Ben-Shlomo Y, Marmot MG. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology. J Neurol Neurosurg Psychiatry 1995;58:293-9.
27. Cumming AM, Robertson F. Polymorphism at the apo E locus in relation to risk of coronary' disease. Clin Genet 1984;25:310-8.
28. Baron JA. Cigarette smoking and Parkinson's disease. Neurology 1988;36:1490-6.
29. Duvoisin RC. The genetics of Parkinson's disease. A review. Adv Neurol 1993;60:306-15.
30. Koller W, Vetere-Overfield B, Gray C, et al. Environmental risk factors in Parkinson's disease. Neurology 1990;40: 1218-21.
31. Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S. Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov Disord 1992;7:149-52.
32. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
33. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state" a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-98.
34. Whelan BJ. RANSAM: a random sample design for Ireland. Economic and Social Review 1979;10:169-74.
35. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982:1-354.
36. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-12.
37. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-8.
38. Gardner MJ, Altman DG. Statistics with confidence-confidence and statistical guidelines. London: BMJ, 1992.
39. Siegal S, Castellan NJ Jr. Non-parametric statistics for the behavioural sciences. New York: McGraw-Hill, 1988: 1-399.
40. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction. An overview of randomised trials. Prog Cardiovasc Dis 1985;27:335-71.
41. Hardy J, Crook R, Prihar G, Roberts G, Raghavan R, Perry R. Senile dementia of the Lewy body type has an apolipoprotein E ε4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett 1994;182: 1-2.
42. Arai H, Muramatsu T, Higuchi S, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet 1994;344:889.
43. Rubinsztein DC, Hanlon CS, Irving RM, et al. Apo E genotypes in multiple sclerosis, Parkinson's disease, scwannomas and late-onset Alzheimer's disease. Mol Cell Probes 1994;8:519-25.
44. Marder K, Maestre G, Cote L, et al. The apolipoprotein ε4 allele in Parkinson's disease with and without dementia. Neurology 1994;44:1330-1.
45. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995;37:242-5.
46. Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 1995;45: 1985-90.
47. Jellinger K. Neuropathological substrates of Alzheimer's disease and Parkinson's disease. J Neural Transm Suppl 1987;24:109-29.
48. Harrington CR, Perry RH, Perry EK, et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 1994;5:215-28.
49. Riggs JE. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet 1993;342: 793-4.
50. van Duijn CM, Havekes LM, Broeckhoven CV, Knijff PD, Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 1995;310:627-31.
51. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathological study. Neurology 1992;42:1142-6.